Company Overview and News
Frankfurt: Thyssenkrupp AG’s chief Heinrich Hiesinger is facing the fight of his career as a pair of activist investors take aim at the German industrial giant.
Market Closing: Benchmark indices after yesterday's breather resumed selling pressure again, with the Sensex losing more than 300 points on weaker rupee and global weakness.
Earnings: Archies has reported net profit of Rs 30.6 crore in the Q4FY18 against loss of Rs 1.6 crore in the same quarter last fiscal.
Earnings Reaction: GVK Power share price rallied 10 percent after the company reported profit at Rs 23.1 crore in March quarter 2018 against loss of Rs 205.8 crore in March quarter 2017.
The market is trading on a negative note this Wednesday afternoon, with the Nifty down 21 points at 10,514 and the Sensex down 19 points at 34,631.
With its acquisition of Bhushan Steel nearing completion, Tata Steel can now formally wear the crown of the largest steelmaker in India. But it's a glory that its close competitor, and now number two, JSW Steel will be eager to take back. And the Sajjan Jindal-company may well do that within weeks.
IMD on Monsoon: India Meteorological Department said it did not see possibility of El Nino this year.
Mumbai, May 23 Midsize private sector lender Yes Bank today said it has recovered Rs 184 crore through the sale of the bankrupt Bhushan Steel to Tata Steel and it will result in a provision write-back of Rs 36 crore. The city-headquartered bank said it had a claim of Rs 325 crore on the Bhushan Steel account, which was the maiden account to be resolved through the Insolvency and Bankruptcy Code process last week.
The market is trading on a negative note on Wednesday morning, with the Nifty down 37 points at 10,499 and the Sensex down 100 points at 34,550.
Mumbai: The BSE Sensex slipped almost 61 points in opening trade today on heavy selling in metals, realty energy and auto stocks amid sustained capital outflows by foreign funds.
New Delhi : The National Company Law Appellate Tribunal on Tuesday issued notice to the resolution professional (RP) and Committee of Creditors (CoC) of Bhushan Steel over the plea filed by its operational creditor L&T. NCLAT also impleaded Tata Steel, whose bid for the debt ridden firm has been approved, as party over L&T plea seeking to recover Rs 900 crore. “Let notice be issued to CoC and RP. File their replies by May 28,” said the NCLAT bench headed by Chairman Justice S J Mukhopadhaya.
New Delhi : Tata Steel on Tuesday said it will raise Rs 16,500 crore through debt instruments to fund Rs 32,500 crore acquisition of Bhushan Steel (BSL).
New Delhi:Domestic giant Tata Steel on Tuesday said it will raise Rs16,500 crore through debt instruments to fund Rs32,500 crore acquisition of Bhushan Steel Ltd (BSL).
Market Closing: Benchmark indices snapped five-day losing streak, led by short covering most beaten down stocks like banks.
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Tuesday agreed to hear the petition by Bhushan Steel’s operational creditor Larsen and Toubro Ltd, challenging an NCLT order on the recovery of its Rs962 crore dues from the insolvent company on priority.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET